|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Career Definitions
Labor Market Reports
Education & Training
Regions
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Inhibiton Therapeutics Announces the Addition of Aaron A. Grunfeld to Its Board of Directors
11/19/2008
CENTENNIAL, Colo.--(BUSINESS WIRE)--Inhibiton Therapeutics, Inc. (OTCBB: IHBT) announced today the appointment of Aaron A. Grunfeld to its board of directors as an independent director. Based in Los Angeles, California, Mr. Grunfeld is an attorney with his own law firm, the Law Offices of Aaron A. Grunfeld & Associates, where he has focused his law practice on securities and corporate matters, including domestic and international transactions, for more than 35 years. As counsel to individuals, corporate clients and investment bankers, Mr. Grunfeld has been involved in more than 50 registered public offerings while counseling clients on issues related to corporate compliance and regulatory issues, merger and reorganization transactions, private placements and other related matters. Mr. Grunfeld received an A.B. in Political Science from UCLA in 1968 and a J.D. from Columbia University in 1971.
|
|
|
|
|
|
|
|
|
|
|
|